Cellular reprogramming by transcription factor engineering

Summary diagram showing the modulation of gene expression by designer transcription factors generated by different platforms. TALE: Transcription activator-like Effector; ZFE: Zinc Finger Effector; CRISPRE: Clustered Regularly Interspaced Short Palindromic Repeats Effector. Recent researches have id...

Celý popis

Uložené v:
Podrobná bibliografia
Vydané v:Current opinion in genetics & development Ročník 28; s. 1 - 9
Hlavní autori: Tsang, Jason CH, Gao, Xuefei, Lu, Liming, Liu, Pentao
Médium: Journal Article
Jazyk:English
Vydavateľské údaje: England Elsevier Ltd 01.10.2014
Predmet:
Animals
Cell Differentiation
Cellular Reprogramming
Genetic Engineering - methods
Humans
Medical Education
Pluripotent Stem Cells - cytology
Transcription Factors - genetics
Transcription Factors - metabolism
ISSN:0959-437X, 1879-0380, 1879-0380
On-line prístup:Získať plný text
Tagy: Pridať tag
Žiadne tagy, Buďte prvý, kto otaguje tento záznam!
Popis
Shrnutí:Summary diagram showing the modulation of gene expression by designer transcription factors generated by different platforms. TALE: Transcription activator-like Effector; ZFE: Zinc Finger Effector; CRISPRE: Clustered Regularly Interspaced Short Palindromic Repeats Effector. Recent researches have identified multiple transcription factors as permissible reprogramming factors to pluripotency and lineage switching. The current standard strategy by ectopic factor overexpression however has intrinsic limitations in studying the reprogramming mechanism. There is a growing interest in engineering novel chimeric reprogramming factors and applying designer transcription factors technology to improve reprogramming efficiency and dissect the process of endogenous pluripotency network reactivation. Here, we provide a concise review on the latest progress in studying cellular reprogramming by transcription factor engineering.
Bibliografia:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
ObjectType-Review-3
content type line 23
ISSN:0959-437X
1879-0380
1879-0380
DOI:10.1016/j.gde.2014.07.001